HOME >> MEDICINE >> NEWS
Rochester study shows ethnic disparities in medicare claims

African Americans and Latinos are more likely to underestimate how long it has been since their last routine screening test for disease -- such as a mammogram, Pap smear, or cholesterol test according to a University of Rochester study that matched patient recollections with Medicare documentation. Researchers are concerned this might be harming the health of minorities in the long run.

"If you ask anyone, "When was the last time you had a mammogram, or a cholesterol test?' almost all people will think it's been a shorter time than it's actually been. Over-reporting happens to all of us," said lead author Kevin Fiscella, M.D., M.P.H. "But our study found that some minorities tend to over-report even more often than other groups of patients. This is a problem that has to be recognized and fixed."

Fiscella, an associate professor of Family Medicine and Community and Preventive Medicine at the University of Rochester Medical Center, said he is not sure why the discrepancy in reporting exists. One theory supported by social psychology research is that African American or Latino patients may feel some pressure to defy stereotypes. So, when doctors or nurses ask them about an event for which they are uncertain, they err on the side of caution and reply affirmatively, he said.

The study is to be published Sept. 29, 2006, in the open access journal BMC Health Services Research.

The University of Rochester collaborated with colleagues from the University of California in Sacramento to analyze 49,645 patient records, matching Medicare claims with patient surveys of the last preventive screening test they had received. The researchers made statistical adjustments for age, gender, income, education level and health status.

With the exception of PSA testing for prostate cancer, results showed that minority patients were more likely to report taking part in a test in the absence of a submitted Medicare claim. In addition to over-re
'"/>

Contact: Leslie Orr
leslie_orr@urmc.rochester.edu
585-275-5774
University of Rochester Medical Center
29-Sep-2006


Page: 1 2

Related medicine news :

1. Rochester spreads knowledge of cancer-related fatigue
2. Rochester study rolls out RU-486 to treat uterine fibroids
3. University of Rochester spin-off secures $2 million in funding
4. Rochester researchers join federal initiative to improve drug safety
5. Rochester launches Cancer Stem Cell Research Program
6. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
7. Penn study finds pro-death proteins required to regulate healthy immune function
8. New study shows promise in reducing surgical risks associated with surgical bleeding
9. New study counts the economic cost of persistent pain in Australia
10. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
11. Most seniors now have drug coverage, U-M study shows

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Rochester study shows ethnic disparities medicare claims

(Date:4/23/2014)... of endogenous neural precursor cells cannot alone compensate ... the perspective of neural plasticity, Dr. Yun Xiang ... observed the effects of functional electrical stimulation treatment ... of basic fibroblast growth factor and epidermal growth ... side. The researchers found that functional electrical stimulation ...
(Date:4/22/2014)... (Chicago) A recently FDA-approved device has been shown ... as much as 50 percent. When coupled with an ... Rush, the device facilitated the complete elimination of seizures ... in the decade-long clinical trials. , That,s good news ... in the U.S. living with epilepsy whose seizures can,t ...
(Date:4/22/2014)... all lung cancers are small cell lung cancers ... to chemotherapy. However, researchers at Virginia Commonwealth University ... the mechanisms leading to this resistance that may ... primarily by mediating B-cell lymphoma 2 (Bcl-2) family ... Depending on their function, this family of proteins ...
(Date:4/22/2014)... Hopkins scientists have found a way to block abnormal ... of atherosclerosis, the main cause of heart attacks and ... The condition develops when fat builds inside blood vessels ... greatly reducing their ability to feed oxygen-rich blood to ... series of experiments, described April 7 in the journal ...
(Date:4/22/2014)... massive health care spending, a new RAND study concludes ... incentivize pharmaceutical companies and device makers to develop products ... medical technologies and their use, a new study suggests ... medical devices get created in the first place. The ... as little loss of health as possible and to ...
Breaking Medicine News(10 mins):Health News:Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy 2Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 4Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3
(Date:1/15/2014)... PHILADELPHIA , Jan. 15, 2014  Echo Therapeutics, Inc. ... company developing its Symphony® CGM System as a non-invasive, ... Robert F. Doman , Executive Chairman and Interim CEO ... Capital Markets, Tenth Annual Equity Conference. ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... and Market Analysis to 2022 ... Dermatitis - India Drug Forecast and Market ...
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: